Company
ProfoundBio
| Industry | clinical-stage biotechnology company developing novel antibody-drug conjugate (ADC) therapeutics for patients with cancer |
|---|
Funding raised
| Company | Round | Date |
|---|---|---|
| ProfoundBio | Series B | 2024-02-13 |
Company
| Industry | clinical-stage biotechnology company developing novel antibody-drug conjugate (ADC) therapeutics for patients with cancer |
|---|
| Company | Round | Date |
|---|---|---|
| ProfoundBio | Series B | 2024-02-13 |